PubRank

Walentyna Zoch-Zwierz

Author PubWeight™ 22.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Assessment of lithogenic risk in children based on a morning spot urine sample. J Urol 2010 1.45
2 KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatr Nephrol 2011 1.23
3 Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity? Pediatr Nephrol 2010 1.11
4 A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index. Pediatr Nephrol 2008 0.92
5 Hypertension in dialysed children: the prevalence and therapeutic approach in Poland--a nationwide survey. Nephrol Dial Transplant 2005 0.91
6 MDR-1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children. Pediatr Nephrol 2006 0.90
7 Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children. Pediatr Nephrol 2007 0.89
8 Effect of cyclosporin A on proteinuria in the course of glomerulopathy associated with WT1 mutations. Eur J Pediatr 2010 0.86
9 Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome. Pediatr Nephrol 2008 0.81
10 Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria. Scand J Urol Nephrol 2010 0.81
11 Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children. Pediatr Nephrol 2010 0.81
12 Evaluation of bladder instability in children with recurrent urinary tract infections. Med Sci Monit 2002 0.81
13 Assessment of serum cystatin C in children with congenital solitary kidney. Pediatr Nephrol 2006 0.81
14 Expression of glucocorticoid receptors in mononuclear cells in nephrotic syndrome. Pediatr Nephrol 2003 0.80
15 A potential pathogenic role of oxalate in autism. Eur J Paediatr Neurol 2011 0.80
16 Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid response. Pediatr Nephrol 2006 0.79
17 Functional bladder capacity and urine osmolality in children with primary monosymptomatic nocturnal enuresis. Scand J Urol Nephrol 2005 0.79
18 Is plasma symmetric dimethylarginine a suitable marker of renal function in children and adolescents? Scand J Urol Nephrol 2011 0.78
19 A need to establish normative data for plasma oxalates. Am J Kidney Dis 2008 0.78
20 Glucocorticoid receptor and vascular endothelial growth factor in nephrotic syndrome. Acta Paediatr 2006 0.78
21 Reference values of plasma oxalate in children and adolescents. Pediatr Nephrol 2008 0.78
22 [Serum and urinary homocysteine in children with steroid-dependent nephrotic syndrome]. Pol Merkur Lekarski 2011 0.77
23 [WT1 mutation as a cause of progressive nephropathy in Frasier syndrome--case report]. Pol Merkur Lekarski 2009 0.77
24 [Chronic peritoneal dialysis in infants--preliminary results of the multicenter survey]. Przegl Lek 2006 0.76
25 Urinary transforming growth factor beta1 in children and adolescents with congenital solitary kidney. Pediatr Nephrol 2008 0.76
26 Laminin and transforming growth factor beta-1 in children with vesicoureteric reflux. Pediatr Nephrol 2008 0.76
27 Serum and urine leptin concentration in children with nephrotic syndrome. Pediatr Nephrol 2005 0.75
28 Expression of glucocorticoid receptors in nephrotic children depending on total prednisone dose. J Pediatr Endocrinol Metab 2005 0.75
29 High-sensitivity C-reactive protein (hs-CRP) level in children with nephrotic syndrome. Pediatr Nephrol 2006 0.75
30 Expression of multidrug resistance P-glycoprotein on lymphocytes from nephrotic children treated with cyclosporine A and ACE-inhibitor. Eur J Pediatr 2006 0.75
31 [The evaluation of urinary tract dysfunction in children with monosymptomatic primary nocturnal enuresis]. Pol Merkur Lekarski 2008 0.75
32 High-sensitivity C-reactive protein and mean platelet volume in paediatric hypertension. Pediatr Nephrol 2010 0.75
33 [Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in the urine of children with pyelonephritis]. Pol Merkur Lekarski 2009 0.75
34 [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children]. Pol Merkur Lekarski 2005 0.75
35 [Assessment of 24-hour blood pressure function of the single kidney in children with renal agenesis]. Pol Merkur Lekarski 2005 0.75
36 [Analysis of vesicoureteral reflux (VUR) course in children]. Pol Merkur Lekarski 2008 0.75
37 [The concentration of plasma anion oxalate in children treatment antibiotics beta lactame]. Pol Merkur Lekarski 2006 0.75
38 [Serum and urinary concentration of selected metalloproteinases and their tissue inhibitors in children with vesicoureteral reflux]. Pol Merkur Lekarski 2010 0.75
39 Vascular endothelial growth factor in children with nephrotic syndrome treated with cyclosporine A. Acta Paediatr 2006 0.75
40 [Evaluation of inflammatory and renal injury markers in youngest children with pyelonephritis]. Pol Merkur Lekarski 2008 0.75
41 Spontaneous urinary calcium oxalate crystallization in hypercalciuric children. Pediatr Nephrol 2009 0.75
42 Serum and urine fibronectin levels in children with vesicoureteral reflux. Pediatr Nephrol 2007 0.75
43 [Assessment of transforming growth factor-beta1 in serum of children with idiopathic nephrotic syndrome depending on the way of treatment]. Pol Merkur Lekarski 2003 0.75
44 [Role of matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) in nephrology]. Przegl Lek 2009 0.75
45 [Reference values of 24-hour ambulatory blood pressure in healthy children by height]. Pol Merkur Lekarski 2004 0.75